Hubei Pharmaceutical

Biocause Pharmaceutical, formerly known as Hubei Biocause Pharmaceutical, is a leading Chinese pharmaceutical manufacturer specializing in Active Pharmaceutical Ingredients (APIs) and finished dosage forms. The company is globally recognized as one of the world's largest producers of Ibuprofen, supplying a significant portion of the global market for this essential analgesic. Its product portfolio also includes treatments for gastrointestinal disorders, respiratory conditions, and musculoskeletal pain. Headquartered in Jingmen, Hubei Province, Biocause is a publicly traded entity on the Shenzhen Stock Exchange and operates large-scale manufacturing facilities that comply with international Good Manufacturing Practice (GMP) standards.